Weishun Tian

Dr. Weishun Tian


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2022 in Toxicology Letters
Verified
Journal Article
Closed access
SLSong Liu
Song Liu
JZJing Zhao
Jing Zhao
WTWeishun Tian
Weishun Tian
Jicang WangJicang Wang
Jicang Wang
HWHongwei Wang
Hongwei Wang
BZBian-Hua Zhou
Bian-Hua Zhou

14 July 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
JZJing Zhao
Jing Zhao
YZYuan Zhao
Yuan Zhao
SSShuzhe Song
Shuzhe Song
SZSai Zhang
Sai Zhang
GYGuodong Yang
Guodong Yang
WTWeishun Tian
Weishun Tian
Acetaminophen (APAP) overdose is a major cause of drug-induced liver injury (DILI) globally, which necessitates effective therapies. Gallic acid (GA), a naturally abundant polyphenol, possesses potent antioxidant and anti-inflammatory properties that may overcome the limitations of N-acetylcysteine (NAC), such as its narrow therapeutic window. This study systematically investigated the hepatoprotective effects and underlying molecular mechanisms of GA against APAP-induced acute liver injury (ALI). Mice received an intraperitoneal injection of APAP (300 mg/kg), followed by an oral administration of GA (50 or 100 mg/kg) or NAC (150 mg/kg) 1 h post-intoxication. Both GA and NAC significantly ameliorated hypertrophy and histopathological damage, as evidenced by reduced serum ALT/AST levels and inflammatory cytokines. TUNEL staining revealed a marked suppression of apoptotic and necrotic cell death, further supported by the downregulation of pro-apoptotic Bax and the upregulation of anti-apoptotic Bcl-2 mRNA expression. GA and NAC treatment restored hepatic glutathione (GSH) content, enhanced antioxidant enzyme gene expression, and reduced malondialdehyde (MDA) accumulation. Mechanistically, GA and NAC inhibited MAPK phosphorylation while activating AMPK signaling. Taken together, these findings demonstrate that GA mitigates APAP-induced ALI by modulating oxidative stress and inflammation through the regulation of MAPK/AMPK signaling proteins.